As one of the richest couples in the world, Mark Zuckerberg and Dr. Priscilla Chan have a lot of money to spend. However, even for the founder of Facebook, $3 billion is still a huge investment. That’s exactly how much they are pledging for the Chan Zuckerberg Initiative, however, which is meant to cure all of the world’s diseases.
As The New York Times reports, the wealthy couple had already committed 99 percent of their shares in Facebook to charity the previous year. This time, they are putting a solid number on how much they are willing to give to a good cause. The $3 billion will be spent on a decade-long crusade to rid the world of its most serious diseases.
The foundation had actually already contributed to multiple causes, including charter schools as well as startups that were related to education. However, the money that the couple is promising is the initiative’s first major impact when it comes to scientific efforts. Then again, curing diseases is more in line with what Dr. Chan specializes in since she is a trained pediatrician.
In a speech she made about the initiative, Dr. Chan described how the move would contribute to the advancement of human potential. She also spoke about the importance of high-quality education, using her case as an example of what it can do for disadvantaged people.
“We want to dramatically improve every life in Max’s generation and make sure we don’t miss a single soul. We’ll be investing in basic science research with the goal of curing disease,” Dr. Chan stated.
Max is actually the couple’s daughter whose full name is Maxima. It was when she was born that the couple decided to pursue charitable actions in earnest.
During the presentation, Mark Zuckerberg himself came out to explain exactly which diseases they plan to tackle with the initiative, Tech Crunch reports. Among the biggest targets listed include cancer, heart disease, neurological diseases, and infectious diseases.


Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements
SpaceX Starship V3 Test Flight Boosts IPO Momentum Ahead of Historic Market Debut
Meta AI Push Could Add $26 Billion in Revenue by 2027, Wolfe Research Says
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments
PDG Explores $1 Billion Sale of China Data Center Assets
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook
Samsung Union Dispute Escalates Over Semiconductor Bonus Vote
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market 



